InsidersTradesSigma
에스티팜 Stock: price and insider trades · South Korea · DART (FSS)
Track the 에스티팜 share price and the full management transaction log of the company, a listed issuer based in South Korea. Shares are listed on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 에스티팜 has published 8 reports. Market capitalisation: €1,965.1bn. The latest transaction was filed on 30 April 2026 (Purchase). Among the most active insiders: 동아쏘시오홀딩스. The full history is accessible without an account.
8
Insider Decl.
n/a
Thresholds
€20m
5 ops.
Buy Volume
€577,438
2 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate 에스티팜 Strong Buy (bullish), based on 10 analysts. Average price target: ₩180,000.
11Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 14,312 of 28,199 companies
51.7
score / 100
Value33
Quality70
FCF yld-1.6%
Earn yld2.6%
EV/EBITDA23.4x
ROE·
Gross mgn41%
Net mgn17%
Debt/EBITDA0.8x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 30 April 2026
Declarations8 total
8 of 8 declarations
About 에스티팜
Listed on the XKRX market, 에스티팜 is a company in the health and pharmaceutical sector. It focuses on the development and production of innovative medicines.